| 000 | 00726nam a2200229 4500 | ||
|---|---|---|---|
| 003 | KMLcat | ||
| 008 | 151015b xxu||||| |||| 00| 0 eng d | ||
| 020 | _a9241590157 | ||
| 041 | _aEng | ||
| 082 |
_a615.1 _bIMP |
||
| 245 | _aThe Importance of pharmacovigilance | ||
| 260 |
_c2000 _aGeneva _bWHO _g2000 |
||
| 300 |
_a48 p. _c24 cm. |
||
| 440 |
_aSafety monitoring of medicinal products _910815 |
||
| 650 | _aPHARMACEUTICAL PREPARATIONS | ||
| 655 |
_aDrug monitoring _910637 |
||
| 655 |
_aAdverse drug reaction reporting _910817 |
||
| 655 |
_aLegislation, drug _910658 |
||
| 655 |
_aPharmaceutical preparations-adverse effects _910818 |
||
| 655 |
_aProduct surveillance, postmarketing _910819 |
||
| 942 |
_s1 _cSPR _2ddc |
||
| 999 |
_c4300 _d4300 |
||